Recent studies have indicated that methionine can serve as an initiator amino acid in eucaryotic protein synthesis. Thus, Jackson, and Hunter (l), using reticulocyte ribosomes synchronized at the point of initiation, have found that the amino-terminal amino acid of short, unfinished hemoglobin chains is methionine, whereas, the N-terminal amino acid of longer and completed chains is valine. Similarly, Wilson and Dintzis have found that 15% of the labeled hemoglobin chains formed by reticulocytes have the N-terminal sequence Met-Val (2) . In vitro evidence in favor of initiation by methionine has been adduced by several laboratories.
Housman et al. (3) have found that yeast methionyl-tRNA's can be fractionated into two species, one of which, when acylated, accepts a formyl group from formyl tetrahydrofolate and one of which does not. They have further shown, using an in vitro protein-synthesizing system from rabbit reticulocytes, that the formylatable species donates its methionine exclusively to the amino terminus of the hemoglobin chains made in this system, while the nonformylatable species supplies internal methionine. Smith and Marcker (4) and Brown and Smith (5) have obtained similar results using ribosomes and methionyl-tRNA's from ascites tumor cells, and similar functions for the methionyl-tRNA's have been demonstrated in other eucaryotic systems (6) .
The initiator function of methionine thus seems well established, yet only a few specific eucaryotic proteins have been shown to be initiated with methionine. These include hemoglobin (7), protamines (8) , and the viral proteins synthesized under the direction of the adenovirus genome (9) . The present study was undertaken to determine whether methionine functions as an initiator amino acid in the mouse plasmacytoma and to further determine whether the specific immunoglobulin chains synthesized by plasmacytoma systems are initiated with methionine. Three plasma cell tumors were used in this study, RPC-20, a A chain producer, MOPC-41, a K chain producer and MOPC-104E, a heavy and light chain producer, the light chain of which is identical in structure to the A chain of RPC-20 (10, 11) . It was of particular interest to investigate the initiation mechanism in tumors RPC-20 and MOPC104E since the L chain' products of these tumors have been shown to possess amino-terminal L-pyroglutamic acid (10) . pGlu has been suggested as an initiator amino acid in immunoglobulin biosynthesis (12) .
While this manuscript was in preparation, Prasad and Peterkofsky presented evidence for the initiation of the RPC-20 light chain synthesis by methionine (13) . The studies presented below confirm these results, extend them to the MOPC-41 and MOPC-104E tumors and also provide information regarding the possibility of initiation by other amino acids in the mouse plasma cell tumor. The peptide material in the aqueous phase from such an extraction was subjected to Sephadex G-50 chromatography, and a single radioactive peak was obtained (data not shown). The leading and trailing halves of this peak were pooled separately, concentrated and subjected to paper electrophoresis with methionine as a reference. None of the peptide fractions (from any of the three tumors tested) contained free methionine (data not shown). Table I shows the  results of Edman degradation of the leading half (fraction A) and trailing half (fraction B) from the three tumors. It can be seen that 7085% of the methionione in fractions A and B from each tumor was released in the first round of Edman degradation.
MATERIALS AND METHODS

Plasma
Since the efficiency of the Edman reaction is generally 7585% for peptides (161, it can be concluded that nearly all methionine in fractions A and B is amino terminal.
The high level of Nterminal methionine found on these small, nascent myeloma peptides suggests that methionine is the initiator amino acid for the synthesis of at least some myeloma proteins. These data support the results obtained in vitro by Jones and Mach with methionyl-tRNA's (20) . Specific information on the molecular sizes of peptides A and B was obtained by chromatography of the phenol-extracted aqueous phases on Sephadex G-10. It was found that the 93 label of peaks A and B eluted in a major peak with a mobility slightly greater than that of reduced glutathione. Skewing toward smaller sizes was also observed (data not shown). Thus, phenol-extraction procedures appear to yield tRNA molecules bearing di-to tetrapeptides.
Is Methionine the Only Initiator Amino Acid Used in Myeloma Protein Synthesis?
To determine whether all proteins in mouse myelomas are initiated with methionine, it was necessary to establish that nascent peptides from myeloma ribosomes contained only methionine as their N-terminal amino acid. To this end, doubly labeled incubations were performed with MOPC-41 and RPC-20 tumor fragments. For these experiments, combinations of lY3lmethionione
and an [3H]amino acid mixture or 13Hlmethionine and a 14[C-] amino acid mixture were used. Short, nascent peptides were prepared by phenol extraction of labeled ribosomes, and peaks A and B from Sephadex G-50 columns were collected together. As a control for this experiment, the high speed supernatant fraction (S200, presumably containing released polypeptide chains which were expected to possess little, if any, N-terminal methionine) from the ribosome pelleting was also prepared. The S2OO's were subjected to Edman degradation along with the nascent peptides from the corresponding incubations.
The results of these experiments are shown in Table II . It can be seen that 70-85% of the [35S]methionine was released after one round of Edman degradation.
Surprisingly, it was observed that l&25% of the tritium counts (amino acids other than methionine)
were also released in the first round for all the tumors tested. This result was also obtained with peptides from tumor fragments labeled singly with methionine or amino acids. These data indicate that methionine is not the only N-terminal amino acid on short, nascent myeloma peptides and suggest that (ilinitiating methionione is removed very rapidly from most nascent polypeptides, before they reach lengths of greater than four to five amino acids; or (ii)amino acids other than methionine participate in initiation in the myeloma. Low percentages of N-terminal methionine and of other amino acids were observed on Edman analysis of the soluble proteins obtained in the S200 H. JONES fractions (Table II) . The biological significance of these latter results is not clear, but the values obtained are similar to those observed on Edman analysis of those nascent myeloma peptides that are excluded from Sephadex G-50 (Table III) (15) after the 30-min incubation. The cell sap (S200) and incubation medium from the 3-h incubation were prepared and processed as described in Materials and Methods.
Labeled light chain was purified from the S200 and cell-free incubation medium by chromatography on DEAE-cellulose (17) . Labeled light chain protein was isolated from labeled ribosomes by DEAE-cellulose and Sephadex G-200 chromatography.
Dodecyl sulfate- a Fractions from the Sephadex G-50 column were pooled as described in Fig. 3 and concentrated by lyophilization.
Aliquots of each peak were subjected to Edman degradation as described by Konigsberg and HiR (16) .
acrylamide-gel electrophoresis of the appropriate fractions from these columns indicated that the major radioactive protein in each case had a mobility similar to authentic light chain and contained at least 90% of the total radioactivity recovered from the gels (data not shown).
The light chains obtained by this procedure were subjected to Edman degradation with the result that 8.14, 0.65 and 0.23%, respectively, of the total incorporated methionine was N-terminal on ribosomebound, released and secreted light chains. These data suggest that at least some ribosome-bound RPC-20 light chains possess N-terminal methionine, whereas released and secreted chains do not. This result was confirmed by the chromatograhic analysis of the ethyl acetate extracts following Edman degradation.
Only the extract from the analysis of ribosome-bound L chain contained PTH-methionine (Fig. 1) . Since methionine is not the amino-terminal amino acid of the RPC-20 light chains isolated from urine or serum (101, initiating methionine must be removed from most L chains before they are completed. Additional evidence in support of this contention is presented below.
Initiating
Methionine is Lost from the Growing Polypeptide Chains Before Their Completion
The data presented above and in Table  II indicate that released and secreted myeloma peptide chains contain little, if any N-terminal methionine.
It was of interest to determine whether the N-terminal methionine found on short, nascent peptide chains was lost after chain completion or at some step during chain growth. For this purpose, labeled nascent chains were used for the preparation of peptidyl tRNA by the procedure of Slabaugh and Morris (15) . Figure 2 depicts the profile of radioactivity obtained on chromatography of the RPC-20 peptidyl tRNA on DEAE-cellulose.
In general, 45-60% of the applied radioactivity was recovered in peak I from the DEAE-cellulose column and 25-35% was recovered in peak II. The materal eluting in peak I was shown by chromatography on Sephadex G-50 to consist mainly of peptides that were excluded from the Sephadex column. Whether this material represents peptides obtained from peptidyl tRNA by deacylation or large peptides that stick nonspecifically to the ribosome has not been determined.
The material in peak II is peptidyl tRNA (15) .
Peptides obtained by deacylation of peak II from the DEAE-cellulose column were separated by gel filtration.
The profile of such a column is shown in Fig. 3 for RPC-20 peptides. Similar profiles were obtained for MOPC-41 and MOPC104E peptides. Peptides of sizes ranging from 1 or 2 to more than 100 amino acids were obtained, with the recovery of radioactivity increasing with increasing peptide chain length. Fractions were pooled as indicated in Fig.  3 and subjected to Edman degradation. The results of typical N-terminal analyses are shown in Table III tested. As one would predict if methionine acts as an initiator amino acid in this system, the percentage of the total methionine in each column cut which was present as N-terminal methionine increased from about 1% in fraction I (greater than 100 amino acids) to about 50% in fraction V (less than 15 amino acids).
DISCUSSION
The data presented above may be summarized as follows: (i)Methionine is present at the N terminus of short, nascent peptides synthesized on mouse plasmacytoma ribosomes; (ii)most methionine in these peptides is N terminal, but methionine is not the only N-terminal amino acid present; (iii)light chains purified from RPC-20 ribosomes possess N-terminal methionine whereas light chains from the cell sap and secreted light chains do not; (iv)the percentage of N-terminal methionine present on nascent myeloma peptides decreases with increasing peptide chain length. Although a maximum of only 50% 
